Latest news

Activatable Antibodies in Targeted Therapies

Brain Glycogen and Neurodegenerative Diseases

Interview with Oriol Martínez Huguet, CEO of GasN2

IQS Teaches its First Bioprocesses Course for Companies

7 QUESTIONS FOR… Gilda Hernández

Hausmann, New Member of the IQS Business Foundation

Introducing Our New Website!

Analysis of Neurotoxic Compounds in Water. COGNIRISK Project
Check our upcoming events
